Impact of a new reimbursement program on hepatitis B antiviral medication cost and utilization in Beijing, China. [electronic resource]
Producer: 20150622Description: e109652 p. digitalISSN:- 1932-6203
- Antiviral Agents -- economics
- China
- Drug Costs -- statistics & numerical data
- Drug Utilization -- economics
- Female
- Health Services -- economics
- Hepatitis B, Chronic -- drug therapy
- Hospitals -- statistics & numerical data
- Humans
- Insurance, Health, Reimbursement -- statistics & numerical data
- Male
- Retrospective Studies
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.